Researchers discover first therapeutic option for patients with rare and aggressive form of mitochondrial disease
Researchers at Children’s Hospital of Philadelphia (CHOP) have discovered a molecule that may have therapeutic benefits for children with a life-threatening form of mitochondrial disease. The findings were published in the journal JCI Insight.